Tubocapsenolide A targets C-terminal cysteine residues of HSP90 to exert the anti-tumor effect
Abstract
Heat shock protein 90 (HSP90) is a chaperone protein that has been shown to regulate cancer progression. As a result, HSP90 has emerged as an attractive target for cancer therapy. Tubocapsenolide A (TA) is an anti-tumor component isolated from Tubocapsicum anomalum. Although the anti-tumor activity of TA was considered to be related to HSP90, the binding site and deep anti-tumor mechanisms still need to be elucidated. In this study, we found...
Paper Details
Title
Tubocapsenolide A targets C-terminal cysteine residues of HSP90 to exert the anti-tumor effect
Published Date
Apr 1, 2021
Journal
Volume
166
Pages
105523 - 105523
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History